What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?

Malaria caused by Plasmodium vivax continues being one of the most important infectious diseases around the world; P. vivax is the second most prevalent species and has the greatest geographic distribution. Developing an effective antimalarial vaccine is considered a relevant control strategy in the...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2017
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24090
Acceso en línea:
https://doi.org/10.3389/fimmu.2017.00126
https://repository.urosario.edu.co/handle/10336/24090
Palabra clave:
Apical membrane antigen 1
Chemokine
Circumsporozoite protein
Duffy binding protein
Malaria vaccine
Merozoite surface protein 3
Merozoite surface protein 9
Protozoal protein
Recombinant protein
Synthetic peptide
Transcription factor
Unclassified drug
Adaptive immunity
Antigen binding
B lymphocyte
Cell invasion
Disease severity
Geographic distribution
Helper cell
Host cell
Human
Immune response
Immunological tolerance
Inflammation
Innate immunity
Macrophage activation
Minor histocompatibility complex
Natural killer cell
Neuromuscular blocking
Nonhuman
Pathogenesis
Phagolysosome
Plasmodium vivax malaria
Review
Serology
Sporozoite
T lymphocyte activation
Vaccine immunogenicity
Antigenicity
Immune response
Immunogenicity
Malaria
Plasmodium vivax
Rights
License
Abierto (Texto Completo)
id EDOCUR2_652d1417a31e06156ca496e525fec390
oai_identifier_str oai:repository.urosario.edu.co:10336/24090
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling f04dd5c4-d685-4cee-a3d9-d2c759ef003f-1cefe4575-665d-4fc3-8e86-c6715477a2fd-17a7ab596-67bd-43b1-9ba1-8ec6c572d2df-179653065-1518948826002020-05-26T00:08:31Z2020-05-26T00:08:31Z2017Malaria caused by Plasmodium vivax continues being one of the most important infectious diseases around the world; P. vivax is the second most prevalent species and has the greatest geographic distribution. Developing an effective antimalarial vaccine is considered a relevant control strategy in the search for means of preventing the disease. Studying parasite-expressed proteins, which are essential in host cell invasion, has led to identifying the regions recognized by individuals who are naturally exposed to infection. Furthermore, immunogenicity studies have revealed that such regions can trigger a robust immune response that can inhibit sporozoite (hepatic stage) or merozoite (erythrocyte stage) invasion of a host cell and induce protection. This review provides a synthesis of the most important studies to date concerning the antigenicity and immunogenicity of both synthetic peptide and recombinant protein candidates for a vaccine against malaria produced by P. vivax. © 2017 López, Yepes-Pérez, Hincapié-Escobar, Díaz-Arévalo and Patarroyo.application/pdfhttps://doi.org/10.3389/fimmu.2017.0012616643224https://repository.urosario.edu.co/handle/10336/24090engFrontiers Research FoundationNo. FEBFrontiers in ImmunologyVol. 8Frontiers in Immunology, ISSN:16643224, Vol.8, No.FEB (2017)https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014341523&doi=10.3389%2ffimmu.2017.00126&partnerID=40&md5=061b587217ac2997fa0bdaf68d6b7f89Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURApical membrane antigen 1ChemokineCircumsporozoite proteinDuffy binding proteinMalaria vaccineMerozoite surface protein 3Merozoite surface protein 9Protozoal proteinRecombinant proteinSynthetic peptideTranscription factorUnclassified drugAdaptive immunityAntigen bindingB lymphocyteCell invasionDisease severityGeographic distributionHelper cellHost cellHumanImmune responseImmunological toleranceInflammationInnate immunityMacrophage activationMinor histocompatibility complexNatural killer cellNeuromuscular blockingNonhumanPathogenesisPhagolysosomePlasmodium vivax malariaReviewSerologySporozoiteT lymphocyte activationVaccine immunogenicityAntigenicityImmune responseImmunogenicityMalariaPlasmodium vivaxWhat is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?articleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501López, CarolinaYepes-Pérez, YoelisHincapié-Escobar, NataliaPatarroyo, Manuel A.Díaz Arévalo, DianaORIGINALfimmu-08-00126.pdfapplication/pdf1773731https://repository.urosario.edu.co/bitstreams/a1ecae58-9543-42f1-b3b9-cb25520ab06e/download3eb4a6e9b184d5c8dfdf73b90a29ed8dMD51TEXTfimmu-08-00126.pdf.txtfimmu-08-00126.pdf.txtExtracted texttext/plain149125https://repository.urosario.edu.co/bitstreams/d4711a53-3273-4a45-9350-343342f3e2f8/download25047bffb210dc808b52e5ef98b22904MD52THUMBNAILfimmu-08-00126.pdf.jpgfimmu-08-00126.pdf.jpgGenerated Thumbnailimage/jpeg4410https://repository.urosario.edu.co/bitstreams/0ecaff03-c362-4cbd-a227-c5c71835f034/download356d11c8fcca34b080e0259b6d4668c8MD5310336/24090oai:repository.urosario.edu.co:10336/240902022-05-02 07:37:21.39403https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?
title What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?
spellingShingle What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?
Apical membrane antigen 1
Chemokine
Circumsporozoite protein
Duffy binding protein
Malaria vaccine
Merozoite surface protein 3
Merozoite surface protein 9
Protozoal protein
Recombinant protein
Synthetic peptide
Transcription factor
Unclassified drug
Adaptive immunity
Antigen binding
B lymphocyte
Cell invasion
Disease severity
Geographic distribution
Helper cell
Host cell
Human
Immune response
Immunological tolerance
Inflammation
Innate immunity
Macrophage activation
Minor histocompatibility complex
Natural killer cell
Neuromuscular blocking
Nonhuman
Pathogenesis
Phagolysosome
Plasmodium vivax malaria
Review
Serology
Sporozoite
T lymphocyte activation
Vaccine immunogenicity
Antigenicity
Immune response
Immunogenicity
Malaria
Plasmodium vivax
title_short What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?
title_full What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?
title_fullStr What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?
title_full_unstemmed What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?
title_sort What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?
dc.subject.keyword.spa.fl_str_mv Apical membrane antigen 1
Chemokine
Circumsporozoite protein
Duffy binding protein
Malaria vaccine
Merozoite surface protein 3
Merozoite surface protein 9
Protozoal protein
Recombinant protein
Synthetic peptide
Transcription factor
Unclassified drug
Adaptive immunity
Antigen binding
B lymphocyte
Cell invasion
Disease severity
Geographic distribution
Helper cell
Host cell
Human
Immune response
Immunological tolerance
Inflammation
Innate immunity
Macrophage activation
Minor histocompatibility complex
Natural killer cell
Neuromuscular blocking
Nonhuman
Pathogenesis
Phagolysosome
Plasmodium vivax malaria
Review
Serology
Sporozoite
T lymphocyte activation
Vaccine immunogenicity
Antigenicity
Immune response
Immunogenicity
Malaria
Plasmodium vivax
topic Apical membrane antigen 1
Chemokine
Circumsporozoite protein
Duffy binding protein
Malaria vaccine
Merozoite surface protein 3
Merozoite surface protein 9
Protozoal protein
Recombinant protein
Synthetic peptide
Transcription factor
Unclassified drug
Adaptive immunity
Antigen binding
B lymphocyte
Cell invasion
Disease severity
Geographic distribution
Helper cell
Host cell
Human
Immune response
Immunological tolerance
Inflammation
Innate immunity
Macrophage activation
Minor histocompatibility complex
Natural killer cell
Neuromuscular blocking
Nonhuman
Pathogenesis
Phagolysosome
Plasmodium vivax malaria
Review
Serology
Sporozoite
T lymphocyte activation
Vaccine immunogenicity
Antigenicity
Immune response
Immunogenicity
Malaria
Plasmodium vivax
description Malaria caused by Plasmodium vivax continues being one of the most important infectious diseases around the world; P. vivax is the second most prevalent species and has the greatest geographic distribution. Developing an effective antimalarial vaccine is considered a relevant control strategy in the search for means of preventing the disease. Studying parasite-expressed proteins, which are essential in host cell invasion, has led to identifying the regions recognized by individuals who are naturally exposed to infection. Furthermore, immunogenicity studies have revealed that such regions can trigger a robust immune response that can inhibit sporozoite (hepatic stage) or merozoite (erythrocyte stage) invasion of a host cell and induce protection. This review provides a synthesis of the most important studies to date concerning the antigenicity and immunogenicity of both synthetic peptide and recombinant protein candidates for a vaccine against malaria produced by P. vivax. © 2017 López, Yepes-Pérez, Hincapié-Escobar, Díaz-Arévalo and Patarroyo.
publishDate 2017
dc.date.created.spa.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:08:31Z
dc.date.available.none.fl_str_mv 2020-05-26T00:08:31Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.3389/fimmu.2017.00126
dc.identifier.issn.none.fl_str_mv 16643224
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/24090
url https://doi.org/10.3389/fimmu.2017.00126
https://repository.urosario.edu.co/handle/10336/24090
identifier_str_mv 16643224
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationIssue.none.fl_str_mv No. FEB
dc.relation.citationTitle.none.fl_str_mv Frontiers in Immunology
dc.relation.citationVolume.none.fl_str_mv Vol. 8
dc.relation.ispartof.spa.fl_str_mv Frontiers in Immunology, ISSN:16643224, Vol.8, No.FEB (2017)
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014341523&doi=10.3389%2ffimmu.2017.00126&partnerID=40&md5=061b587217ac2997fa0bdaf68d6b7f89
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Frontiers Research Foundation
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/a1ecae58-9543-42f1-b3b9-cb25520ab06e/download
https://repository.urosario.edu.co/bitstreams/d4711a53-3273-4a45-9350-343342f3e2f8/download
https://repository.urosario.edu.co/bitstreams/0ecaff03-c362-4cbd-a227-c5c71835f034/download
bitstream.checksum.fl_str_mv 3eb4a6e9b184d5c8dfdf73b90a29ed8d
25047bffb210dc808b52e5ef98b22904
356d11c8fcca34b080e0259b6d4668c8
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167668475822080